CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 834 of 870
Non-Antibody Products
Page 834 of 870
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| UC2288 | A p21WAF1 inhibitor; reduces the protein levels and mRNA expression of p21… | 50 mg | 37380-50 | More Info |
| UCB 9260 | A TNF inhibitor; binds to trimeric TNF (Kd = 13.8 nM); selectively increas… | 10 mg | 37336-10 | More Info |
| UCB 9260 | A TNF inhibitor; binds to trimeric TNF (Kd = 13.8 nM); selectively increas… | 25 mg | 37336-25 | More Info |
| UCB 9260 | A TNF inhibitor; binds to trimeric TNF (Kd = 13.8 nM); selectively increas… | 5 mg | 37336-5 | More Info |
| UCB 9260 | A TNF inhibitor; binds to trimeric TNF (Kd = 13.8 nM); selectively increas… | 50 mg | 37336-50 | More Info |
| UCF 101 | A specific inhibitor of the proteolytic activity of Omi / HtrA2 (IC50 = 9.… | 1 mg | 15550-1 | More Info |
| UCF 101 | A specific inhibitor of the proteolytic activity of Omi / HtrA2 (IC50 = 9.… | 10 mg | 15550-10 | More Info |
| UCF 101 | A specific inhibitor of the proteolytic activity of Omi / HtrA2 (IC50 = 9.… | 25 mg | 15550-25 | More Info |
| UCF 101 | A specific inhibitor of the proteolytic activity of Omi / HtrA2 (IC50 = 9.… | 5 mg | 15550-5 | More Info |
| UCLA gp130 2 | A humanin peptide mimetic; inhibits NMDA-induced LDH release in primary mo… | 10 mg | 35551-10 | More Info |
| UCLA gp130 2 | A humanin peptide mimetic; inhibits NMDA-induced LDH release in primary mo… | 25 mg | 35551-25 | More Info |
| UCLA gp130 2 | A humanin peptide mimetic; inhibits NMDA-induced LDH release in primary mo… | 5 mg | 35551-5 | More Info |
| UCLA gp130 2 | A humanin peptide mimetic; inhibits NMDA-induced LDH release in primary mo… | 50 mg | 35551-50 | More Info |
| UCL-TRO-1938 | An allosteric PI3Kα activator; It binds to PI3Kα in an SPR ass… | 1 mg | 39118-1 | More Info |
| UCL-TRO-1938 | An allosteric PI3Kα activator; It binds to PI3Kα in an SPR ass… | 10 mg | 39118-10 | More Info |
| UCL-TRO-1938 | An allosteric PI3Kα activator; It binds to PI3Kα in an SPR ass… | 5 mg | 39118-5 | More Info |
| UCM05 | An inhibitor of FASN that strongly suppresses the growth of human breast c… | 1 mg | 19090-1 | More Info |
| UCM05 | An inhibitor of FASN that strongly suppresses the growth of human breast c… | 10 mg | 19090-10 | More Info |
| UCM05 | An inhibitor of FASN that strongly suppresses the growth of human breast c… | 5 mg | 19090-5 | More Info |
| UCM53 | An inhibitor of bacterial cell division; binds to the GTP site of the cell… | 1 mg | 21768-1 | More Info |
| UCM53 | An inhibitor of bacterial cell division; binds to the GTP site of the cell… | 10 mg | 21768-10 | More Info |
| UCM53 | An inhibitor of bacterial cell division; binds to the GTP site of the cell… | 5 mg | 21768-5 | More Info |
| UCM53 | An inhibitor of bacterial cell division; binds to the GTP site of the cell… | 500 µg | 21768-500 | More Info |
| UCM707 | A 3-furyl arachidonoyl analog that acts as a potent and selective reuptake… | 10 mg | 10045-10 | More Info |
| UCM707 | A 3-furyl arachidonoyl analog that acts as a potent and selective reuptake… | 25 mg | 10045-25 | More Info |
| UCM707 | A 3-furyl arachidonoyl analog that acts as a potent and selective reuptake… | 5 mg | 10045-5 | More Info |
| UCM707 | A 3-furyl arachidonoyl analog that acts as a potent and selective reuptake… | 50 mg | 10045-50 | More Info |
| UCN-01 | A synthetic derivative of staurosporine that inhibits a variety of kinases… | 1 mg | 18130-1 | More Info |
| UCN-02 | A PKC inhibitor (IC50 = 62 nM) that is cytotoxic to the growth of HeLa S3… | 1 mg | 20221-1 | More Info |
| UCN-02 | A PKC inhibitor (IC50 = 62 nM) that is cytotoxic to the growth of HeLa S3… | 5 mg | 20221-5 | More Info |
| UCPH-101 | A noncompetitive inhibitor of EAAT1; selective for EAAT1 over EAAT2 and EA… | 1 mg | 21460-1 | More Info |
| UCPH-101 | A noncompetitive inhibitor of EAAT1; selective for EAAT1 over EAAT2 and EA… | 5 mg | 21460-5 | More Info |
| UCPH-101 | A noncompetitive inhibitor of EAAT1; selective for EAAT1 over EAAT2 and EA… | 500 µg | 21460-500 | More Info |
| Udenafil | A PDE5 inhibitor; increases lung cGMP levels, attenuates the development o… | 10 mg | 30373-10 | More Info |
| Udenafil | A PDE5 inhibitor; increases lung cGMP levels, attenuates the development o… | 25 mg | 30373-25 | More Info |
| Udenafil | A PDE5 inhibitor; increases lung cGMP levels, attenuates the development o… | 5 mg | 30373-5 | More Info |
| Udenafil | A PDE5 inhibitor; increases lung cGMP levels, attenuates the development o… | 50 mg | 30373-50 | More Info |
| UDP-α-D-Galactose (sodium salt) | A nucleotide sugar; an agonist of the purinergic P2Y14 receptor (EC50 = 0.… | 10 mg | 34664-10 | More Info |
| UDP-α-D-Galactose (sodium salt) | A nucleotide sugar; an agonist of the purinergic P2Y14 receptor (EC50 = 0.… | 25 mg | 34664-25 | More Info |
| UDP-α-D-Galactose (sodium salt) | A nucleotide sugar; an agonist of the purinergic P2Y14 receptor (EC50 = 0.… | 5 mg | 34664-5 | More Info |
| UDP-α-D-Galactose (sodium salt) | A nucleotide sugar; an agonist of the purinergic P2Y14 receptor (EC50 = 0.… | 50 mg | 34664-50 | More Info |
| UDP-α-D-Glucose (sodium salt hydrate) | An endogenous nucleotide sugar that binds the P2Y14 receptor (EC50 = 0.35… | 1 g | 15602-1 | More Info |
| UDP-α-D-Glucose (sodium salt hydrate) | An endogenous nucleotide sugar that binds the P2Y14 receptor (EC50 = 0.35… | 100 mg | 15602-100 | More Info |
| UDP-β-D-Glucose (sodium salt) | A stereoisomer of UDP-α-D-glucose | 1 g | 21620-1 | More Info |
| UDP-β-D-Glucose (sodium salt) | A stereoisomer of UDP-α-D-glucose | 100 mg | 21620-100 | More Info |
| UDP-β-D-Glucose (sodium salt) | A stereoisomer of UDP-α-D-glucose | 250 mg | 21620-250 | More Info |
| UDP-β-D-Glucose (sodium salt) | A stereoisomer of UDP-α-D-glucose | 500 mg | 21620-500 | More Info |
| UDP-β-S (sodium salt) | A P2Y6 receptor agonist; selectively induces inositol phosphate accumulati… | 2.1 mg | 38493-21 | More Info |
| UDP-Glucuronic Acid (sodium salt hydrate) | A source of glucuronic acid for polysaccharide biosynthesis; used for the… | 10 mg | 20674-10 | More Info |
| UDP-Glucuronic Acid (sodium salt hydrate) | A source of glucuronic acid for polysaccharide biosynthesis; used for the… | 25 mg | 20674-25 | More Info |
| UDP-Glucuronic Acid (sodium salt hydrate) | A source of glucuronic acid for polysaccharide biosynthesis; used for the… | 5 mg | 20674-5 | More Info |
| UDP-N-acetyl-D-Galactosamine (sodium salt) | A nucleotide sugar; used by glycosyltransferases to glycosylate various su… | 1 mg | 36506-1 | More Info |
| UDP-N-acetyl-D-Galactosamine (sodium salt) | A nucleotide sugar; used by glycosyltransferases to glycosylate various su… | 10 mg | 36506-10 | More Info |
| UDP-N-acetyl-D-Galactosamine (sodium salt) | A nucleotide sugar; used by glycosyltransferases to glycosylate various su… | 25 mg | 36506-25 | More Info |
| UDP-N-acetyl-D-Galactosamine (sodium salt) | A nucleotide sugar; used by glycosyltransferases to glycosylate various su… | 5 mg | 36506-5 | More Info |
| UDP-N-acetyl-D-Glucosamine (sodium salt hydrate) | A nucleotide sugar that is used by glycosyltransferases to transfer N-acet… | 10 mg | 20353-10 | More Info |
| UDP-N-acetyl-D-Glucosamine (sodium salt hydrate) | A nucleotide sugar that is used by glycosyltransferases to transfer N-acet… | 25 mg | 20353-25 | More Info |
| UDP-N-acetyl-D-Glucosamine (sodium salt hydrate) | A nucleotide sugar that is used by glycosyltransferases to transfer N-acet… | 50 mg | 20353-50 | More Info |
| UDP (sodium salt hydrate) | The diphosphate of uridine; a specific agonist of the P2Y purinoceptor P2Y… | 1 g | 18137-1 | More Info |
| UDP (sodium salt hydrate) | The diphosphate of uridine; a specific agonist of the P2Y purinoceptor P2Y… | 100 mg | 18137-100 | More Info |
| UDP (sodium salt hydrate) | The diphosphate of uridine; a specific agonist of the P2Y purinoceptor P2Y… | 500 mg | 18137-500 | More Info |
| U-47931E | An analytical reference standard categorized as a utopioid; has antinocice… | 1 mg | 20530-1 | More Info |
| U-47931E | An analytical reference standard categorized as a utopioid; has antinocice… | 5 mg | 20530-5 | More Info |
| U-48753E (maleate) | A nontricyclic antidepressant that has been shown to modulate signaling th… | 1 mg | 20734-1 | More Info |
| U-48753E (maleate) | A nontricyclic antidepressant that has been shown to modulate signaling th… | 5 mg | 20734-5 | More Info |
| UF010 | A class I HDAC inhibitor (IC50s = 0.06, 0.1, 0.5, and 1.5 µM for HDA… | 10 mg | 21273-10 | More Info |
| UF010 | A class I HDAC inhibitor (IC50s = 0.06, 0.1, 0.5, and 1.5 µM for HDA… | 25 mg | 21273-25 | More Info |
| UF010 | A class I HDAC inhibitor (IC50s = 0.06, 0.1, 0.5, and 1.5 µM for HDA… | 5 mg | 21273-5 | More Info |
| UF010 | A class I HDAC inhibitor (IC50s = 0.06, 0.1, 0.5, and 1.5 µM for HDA… | 50 mg | 21273-50 | More Info |
| UF-17 (hydrochloride) | An analytical reference standard that is structurally similar to known uto… | 1 mg | 27925-1 | More Info |
| UF-17 (hydrochloride) | An analytical reference standard that is structurally similar to known uto… | 5 mg | 27925-5 | More Info |
| UFP101 (trifluoroacetate salt) | A synthetic peptide and nociceptin receptor antagonist (Ki = 0.06 nM in CH… | 1 mg | 36833-1 | More Info |
| UFP101 (trifluoroacetate salt) | A synthetic peptide and nociceptin receptor antagonist (Ki = 0.06 nM in CH… | 5 mg | 36833-5 | More Info |
| UFP101 (trifluoroacetate salt) | A synthetic peptide and nociceptin receptor antagonist (Ki = 0.06 nM in CH… | 500 µg | 36833-500 | More Info |
| U-74389G | U-74389G is an antioxidant which prevents iron-dependent lipid peroxidatio… | 100 mg | 75860-100 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile